AIM-listed biotech firms face crunch votes on London Stock Exchange exits Tech Redx Pharma and C4X Discovery have scheduled general meetings this week to vote on proposals for delisting from the London Stock Exchange.
Redx Pharma denies US listing plan following report AIM Redx Pharma has denied it is currently in the process of listing in the US following a report in The Times.
Redx Pharma signs $880m deal with Nasdaq-listed Jazz Pharmaceuticals Acquisition Redx Pharma has signed a deal worth $880m with a Nasdaq-listed US counterpart.
